Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple human vault RNAs. Expression and association with the vault complex.

A van Zon1, M H Mossink, M Schoester

  • 1Institute of Hematology, Erasmus University Rotterdam, 3015 GE Rotterdam, The Netherlands.

The Journal of Biological Chemistry
|August 2, 2001
PubMed
Summary

Human vaults, involved in multidrug resistance, bind vault RNAs differently. While hvg1 is abundant, hvg3 increases in resistant cells, suggesting RNA ratios are functionally important.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022
Same author

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Human vaults are intracellular ribonucleoprotein particles implicated in multidrug resistance.
  • Vaults comprise major vault protein (MVP), minor vault proteins (VPARP, TEP1), and vault RNAs (HVG1-4).
  • Previous studies showed in vivo association of only hvg1 with vaults, though in vitro studies suggested broader RNA interactions.

Purpose of the Study:

  • To investigate the expression and vault association of different vault RNAs in various cell lines.
  • To compare vault RNA profiles in drug-sensitive versus multidrug-resistant cell lines.
  • To determine the functional significance of vault RNA ratios in cellular processes.

Main Methods:

  • Analysis of vault RNA expression across multiple human cell lines.

Related Experiment Videos

  • Isolation and purification of vaults from cell lines.
  • Quantification of vault RNA species associated with isolated vaults.
  • Comparison of vault RNA profiles in drug-sensitive and multidrug-resistant cell lines.
  • Main Results:

    • Human vault RNAs HVG1-3 were expressed in all examined cell lines, while HVG4 was not detected.
    • HVG1 constituted the majority of vault RNA associated with purified vaults.
    • Vaults isolated from multidrug-resistant cell lines showed a notable increase in associated HVG3.
    • HVG4 expression was likely absent due to missing promoter elements.

    Conclusions:

    • Vaults exhibit differential binding affinities for vault RNAs depending on cellular context.
    • The ratio of vault RNAs associated with vaults may play a crucial role in vault function, particularly in multidrug resistance.
    • HVG3's increased association with vaults in resistant cells suggests a specific role in this phenotype.